Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
EVERESTO Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Moderate ROE but improving trend
Low and declining Debt to Equity
Negative
Expensive and at a premium to industry median P/E
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Low operating margin but improving trend
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.157629.
Snapshot
See detailed analysis
EVERESTO Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
EVERESTO Bulk, Block & Insider Trades
EVERESTO Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Others
Capital Reduction (CRD)Share capital to be reduced from 9273000 shares to 3338280 shares. Ex-date: 12th Aug 2015 Announced on: 10th Aug 2015
Company Profile
Everest Organics Limited is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and intermediaries. It is involved in the manufacturing of bulk drugs. The Company’s API products include Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate, ... Read More
Key personnel
Mr. Prasad Venkata Sundara SrikakolapuD
Non-Executive Chairman Non-Independent of the Board
Dr. Srikakarlapudi Sirisha
Chief Executive Officer, Managing Director
Mr. P. Ramakrishna
Chief Financial Officer
Ms. Shweta Singh
Compliance Officer, Company Secretary
Mr. M. Bangara RajuD
Executive Independent Director, Director - Human Resources, Legal & Corporate Affairs
Mr. Srikakarlapudi HarikrishnaD
Whole-time Director
S.K.Hari KrishnaD
Executive Director
Mr. Kirankumar RampallyD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Everest Organics Ltd.?
The current share price of Everest Organics Ltd. is ₹ 500.35 as of 09 Jan 2026.
What is the PE ratio of Everest Organics Ltd.?
The Price-to-Earnings (PE) ratio of Everest Organics Ltd. is 73.47 as of the latest financial data.
What is the ROE and ROCE of Everest Organics Ltd.?
Everest Organics Ltd. has a Return on Equity (ROE) of 11.71% and a Return on Capital Employed (ROCE) of 10.26% as per the latest financial reports.
What is the market cap of Everest Organics Ltd.?
The market capitalization of Everest Organics Ltd. stands at ₹ 485.89 Cr.
What is the dividend yield of Everest Organics Ltd.?
The dividend yield of Everest Organics Ltd. is 0.00% based on the current market price.
What is the RSI of Everest Organics Ltd.?
The Relative Strength Index (RSI) of Everest Organics Ltd. is 56.50.
What is the FII and DII holding in Everest Organics Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.02% of Everest Organics Ltd. shares.
What sector does Everest Organics Ltd. belong to?
Everest Organics Ltd. operates in the Healthcare sector.
What is the beta of Everest Organics Ltd. stock?
The beta of Everest Organics Ltd. stock is 0.29, indicating its volatility relative to the broader market.
